Nutex Health Inc (NASDAQ:NUTX) traded with an addition of $0.01 to close at $0.20on Friday, an upside of 3.32 percent. An average of 865,839 shares of common stock have been traded in the last five days. There was a gain of $0.0004 in the past week, and it reached a new high 7 times over the past 12 months. The last 20 days have seen an average of 2,960,935 shares traded, while the 50-day average volume stands at 2,033,774.
NUTX stock has decreased by -36.11% in the last month. The company shares reached their 1-month lowest point of $0.1847 on 09/25/23. With the stock rallying to its 52-week high on 01/04/23, shares of the company touched a low of $0.18 and a high of $2.46 in 52 weeks. It has reached a new high 2 times so far this year and lost -89.51% or -$1.7008 in price. In spite of this, the price is down -91.89% from the 52-week high.
Insider Transactions
NUTX stock investors should be aware that Nutex Health Inc (NUTX) stock had its last reported insider trading activity 290 days ago on Aug 31. In this transaction, the insider spent $90,560. 10% Owner, Premier Macy Management Holdin, disposed of 125,498 shares at a price of $2.21 on Dec 12. The insider now owns more than $276,773 worth of shares.
Valuation Metrics
Nutex Health Inc (NUTX) has a trailing price-to-earnings (P/E) ratio of N/A for the broader industry. The stock’s beta is 0.78. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.67, the price-to-book (PB) ratio at 1.42.
Financial Health
The quick ratio of Nutex Health Inc for the three months ended June 29 was 1.56, and the current ratio was 1.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 2.83 and a total debt to equity ratio of 3.10 for the quarter ending June 29. Its gross profit as reported stood at $13.45 million compared to revenue of $219.29 million.
Earnings Surprise
For the three-month period that ended June 29, Nutex Health Inc had $25.11 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$3.48 million in the quarter, while revenues of -$5.15 million were shrunk -457.47%. The analyst consensus anticipated Nutex Health Inc’s latest quarter earnings to come in at $0 per share, but it turned out to be -$0.01. For the quarter, EBITDA amounted to $3.8 million. Shareholders own equity worth $661.9 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Nutex Health Inc (NUTX) price momentum. RSI 9-day as of the close on 28 September was 36.45%, suggesting the stock is Neutral, with historical volatility in this time frame at 68.29%.
As of today, NUTX’s price is $0.1937 +0.20% or $0.0004 from its 5-day moving average. NUTX is currently trading -28.06% lower than its 20-day SMA and -61.20% lower than its 100-day SMA. However, the stock’s current price level is -51.41% below the SMA50 and -89.40% below the SMA200.
The stochastic %K and %D were 11.44% and 9.16%, respectively, and the average true range (ATR) was 0.0190. With the 14-day stochastic at 18.61% and the average true range at 0.0223, the RSI (14) stands at 35.36%. The stock has reached -0.0045 on the 9-day MACD Oscillator while the 14-day reading was at -0.0126.
Analyst Ratings
Northland Capital launched coverage on Nutex Health Inc (NASDAQ: NUTX) in its analyst report released on February 22, 2023. The firm assigned the stock an Outperform rating. The consensus rating for Nutex Health Inc (NUTX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell NUTX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
